Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. - Wikidata - wikimedia - TriplyDB

Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections.

Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections.

http://www.wikidata.org/entity/Q35139786

about

Clostridium difficile in the ICU: the struggle continues Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes.Conventional and alternative treatment approaches for Clostridium difficile infection Clostridium difficile Infection and Fecal Microbiota Transplant.Clostridium difficile infection: guideline-based diagnosis and treatment Emerging technologies for the clinical microbiology laboratory.Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update.Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens Indeterminate tcdB using a Clostridium difficile PCR assay: a retrospective cohort study Phenotypic and genotypic analysis of Clostridium difficile isolates: a single-center study.Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection.A prospective study of two isothermal amplification assays compared with real-time PCR, CCNA and toxigenic culture for the diagnosis of Clostridium difficile infection.Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in Stool Comparison of BD GeneOhm Cdiff and Seegene Seeplex ACE PCR assays using toxigenic Clostridium difficile culture for direct detection of tcdB from stool specimens.Outcomes in patients tested for Clostridium difficile toxins.Evaluation of Clostridium difficile fecal load and limit of detection during a prospective comparison of two molecular tests, the illumigene C. difficile and Xpert C. difficile/Epi tests.Quantitative fecal lactoferrin in toxin-positive and toxin-negative Clostridium difficile specimens.Clostridium difficile testing: have we got it right?Implementing automated surveillance for tracking Clostridium difficile infection at multiple healthcare facilities.Evaluation of an algorithmic approach in comparison with the Illumigene assay for laboratory diagnosis of Clostridium difficile infection Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing?Evaluation of a new automated homogeneous PCR assay, GenomEra C. difficile, for rapid detection of Toxigenic Clostridium difficile in fecal specimens.Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection Alerting physicians during electronic order entry effectively reduces unnecessary repeat PCR testing for Clostridium difficile.A cost-effective approach for detection of toxigenic Clostridium difficile: toxigenic culture using ChromID Clostridium difficile agar.Economic evaluation of laboratory testing strategies for hospital-associated Clostridium difficile infection.Molecular methods in the diagnosis of Clostridium difficile infections: an update.Comparison of Simplexa universal direct PCR with cytotoxicity assay for diagnosis of Clostridium difficile infection: performance, cost, and correlation with disease.Diagnosis of Clostridium difficile infection: the molecular approach.Asymptomatic Clostridium difficile colonization as a reservoir for Clostridium difficile infection.Sample-to-result molecular infectious disease assays: clinical implications, limitations and potential.Clostridium difficile infection: epidemiology, diagnosis and understanding transmission.Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.Inappropriate Clostridium difficile Testing and Consequent Overtreatment and Inaccurate Publicly Reported Metrics.Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.Strategies for Optimizing the Diagnostic Predictive Value of Clostridium difficile Molecular Diagnostics.Impact of a Healthcare Provider Educational Intervention on Frequency of Clostridium difficile Polymerase Chain Reaction Testing in Children: A Segmented Regression Analysis.

P2860

Q26823000-573778E5-2734-4F66-8E2E-229E17FC7362 Q30196898-80ACF3D7-9FB8-4474-99DE-E104FCD8A111 Q30235278-123CE054-2251-42FD-AB76-9B169CF072C0 Q30240065-C1888352-B438-4A13-AA79-E3911BF71918 Q30316981-72BB1BDB-9123-4565-BB4C-C4E597BAC026 Q34297668-182F8A19-C5C2-41F0-8F09-48820FD7D4C0 Q34419009-D7E24304-0F28-4831-9D9E-6E7B54A69479 Q34628889-B99B54AE-AF57-4AC8-BEBD-47BA4275A1F6 Q34832564-3FBAEBF7-637B-4D1A-8670-0A5BD1DBDA8E Q35036237-A8C9EA46-F824-4ACA-B729-3AD4D2E6E457 Q35807076-FBFCAD47-04BF-4C4A-9BAF-FB7129DCD0CB Q35921501-8E8570A7-D52A-4954-8702-2EE6B99D25F6 Q36059395-2EA92780-55C3-489C-B1B1-72877C7DF82A Q36066827-EF4872DD-E208-48C1-B5D2-3540BE58943D Q36363103-7B78BC4F-7A49-4044-A2EE-72E3EFB16780 Q36395224-499815B9-D330-4C0B-9BDC-3924C5B63818 Q36506325-BC69010E-CB7D-4138-AD94-F4D14AF5484E Q36506386-DCE50956-6649-4A9A-ABFE-A4EB481330FE Q36506418-37D4ADB3-33BB-4530-97FE-F96F8EAC2EB6 Q36831094-F12C2D7A-3DB5-4D44-9B8D-8760D852383A Q36884365-A705A3E3-C5DA-4193-8F8A-29ED65BF82D0 Q37035829-99C6C265-D867-4F52-AC2E-E3B64B070AB3 Q37103258-587D4BC8-039C-47C3-B1E3-0BBF7A4CBE90 Q37120875-85DDFBD3-2D1F-47EF-859D-F95E9EC43059 Q37125031-862E3364-BEEC-4ED2-A00F-CB4A22168F4E Q37293591-EC10F02C-3250-4B38-ACE9-58AAA5336F91 Q37470515-BFDE31E1-1433-475F-8EB8-6DBF0B40EB86 Q37546108-1D1A780D-1C99-47A5-AB33-D3EBC5AC97B3 Q37546208-5DA4F8C7-4896-4B57-8F3B-5953BCC827CD Q38142247-645127DD-A295-4FE4-A1E5-FF400CDD66FC Q38162391-342BCC6D-B575-45F4-A030-23AC01424F3E Q38165197-242161CB-21A8-4993-8F7F-4408C45278EA Q38213461-E2322320-D516-457A-B73C-1F7EEF39A87D Q38675080-1C477ADC-5D71-442E-9A51-0088F293745D Q38765888-A7447DFB-7243-48B5-8912-AC8385DA4104 Q38934992-4F7DF8C2-FCAF-461C-A263-CFE0932BBF39 Q38964033-1D208536-0A67-46E4-A32C-AB044BAEFEC6 Q39121704-8BB0FD2B-E6BF-4E75-8425-A25C85060761 Q40302301-40B1C592-3C86-4749-989C-B47476B66F3C Q40670587-9ED44ADA-C516-4A62-8417-054381617037

P2860

Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections.

http://www.wikidata.org/entity/Q35139786

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Impact of clinical symptoms on ...... stridium difficile infections.

@ast

Impact of clinical symptoms on ...... stridium difficile infections.

@en

type

label

Impact of clinical symptoms on ...... stridium difficile infections.

@ast

Impact of clinical symptoms on ...... stridium difficile infections.

@en

prefLabel

Impact of clinical symptoms on ...... stridium difficile infections.

@ast

Impact of clinical symptoms on ...... stridium difficile infections.

@en

P1433

Q35139786-67FC1DFA-C7F7-4A0E-81E5-2E07B3CA313C

P1476

Q35139786-2A711F53-D636-4B4E-AC09-635B860B8C9B

P2093

Q35139786-0A9B5432-9671-43B8-B893-F11924D290C3

Q35139786-29EEA33D-BA8A-4351-B939-EB6E59CC7C70

Q35139786-359D0164-EF97-4938-8259-BB09F04494E0

Q35139786-89FE9158-05C4-401E-9B8D-7D08FB7572F2

Q35139786-B80C6962-FE2D-49FA-BE5F-D3EBE8709988

Q35139786-BB225C81-B795-45BF-BE4A-100EB302AB74

Q35139786-C5FEF841-39BD-4E0F-901D-714605267725

Q35139786-E11A8BBD-9B3A-49F5-AAB1-8D59E6052180

P2860

Q35139786-0E5DDB0A-1DD8-44B8-853F-0F42F19C001C

Q35139786-123CAC13-D3C6-474A-8CFD-4F49FCB32D8A

Q35139786-222D9B18-8ED2-4B0A-B946-C1BF65F9A039

Q35139786-30585489-FF50-4245-B0FA-1B1515815808

Q35139786-382FAB37-1BEC-4B45-957F-E17CF779293D

Q35139786-38F15AA7-CA4A-4D74-A6A7-A77F31A8A690

Q35139786-3F4AF423-8CB1-4419-8DE5-5B4BB68ED8FC

Q35139786-7E8529BB-F782-414C-8B95-7ED68B9FFE77

Q35139786-897B7AED-25DF-4E02-8E87-EE2459B1C0EF

Q35139786-9E9146C5-24E7-42E0-95C5-7459162088DA

P304

Q35139786-255B5C84-A76B-4811-BDDF-C7A59D952014

P31

Q35139786-E330AD52-85A3-4D28-AC6E-9E9965ED1173

P356

Q35139786-4BD448AB-30B1-4464-83FC-124758021434

P407

Q35139786-51E24A64-4C56-4BF8-8F61-FA7F6152874C

P433

Q35139786-7DD763F1-5822-48D6-8997-F0DB9C4698C4

P478

Q35139786-424FB7AB-8E7B-455D-8D7B-67DBABA3FD4D

P50

Q35139786-C4C7815E-5B53-4E9A-BBB2-0FF72428E974

P577

Q35139786-2517678E-3923-48F2-B667-78EB80DA6FE1

P698

Q35139786-BC1D0EA1-E81E-4CAF-BBCF-505818567D75

P921

Q35139786-0E2B97E2-9B79-4DBD-AD76-9CB5004E8F03

P932

Q35139786-487C5AFF-F2F4-4547-B407-0F049B9FC718

P356

P1433

Journal of Clinical Microbiology

P1476

Impact of clinical symptoms on ...... stridium difficile infections.

@en

P2093

Brenda Lawrence

http://www.w3.org/2001/XMLSchema#string

Carey-Ann D Burnham

http://www.w3.org/2001/XMLSchema#string

Joan Hoppe-Bauer

http://www.w3.org/2001/XMLSchema#string

Linda Bobo

http://www.w3.org/2001/XMLSchema#string

Susan Copper

http://www.w3.org/2001/XMLSchema#string

Tiffany Hink

http://www.w3.org/2001/XMLSchema#string

William Michael Dunne

http://www.w3.org/2001/XMLSchema#string

Zhuolin Han

http://www.w3.org/2001/XMLSchema#string

P2860

Fecal lactoferrin, interleukin-1beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

A Clostridium difficile infection "intervention": change in toxin assay results in fewer C difficile infection cases without changes in patient outcomes.

Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.

Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.

Use of cycloserine-cefoxitin-fructose agar and L-proline-aminopeptidase (PRO Discs) in the rapid identification of Clostridium difficile.

Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods.

Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.

Neutralization of Clostridium difficile toxin by Clostridium sordellii antitoxins.

What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection?

P304

2887-2893

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.00891-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

Erik R Dubberke

P577

2011-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21697328

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

3147743

http://www.w3.org/2001/XMLSchema#string